Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

NCT01688960 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: nesvacumab (REGN910/ SAR307746)
DRUG: nesvacumab (REGN910/ SAR307746)
DRUG: nesvacumab (REGN910/ SAR307746)
DRUG: aflibercept (ziv-aflibercept)
DRUG: aflibercept (ziv-aflibercept)

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]